Oxygen therapy for cerebral malaria
Travel Medicine and Infectious Disease, ISSN: 1477-8939, Vol: 9, Issue: 5, Page: 223-230
2011
- 2Citations
- 34Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Malaria is an important global health issue, killing nearly one million people worldwide each year. There is a disproportionate disease burden, since 89% of cases are of African origin, and 85% of deaths worldwide occur in children under 5 years of age of age. 1 Cerebral malaria (CM) is the most serious complication of infection. Despite prompt anti-malarial treatment, fatalities remain high – mortality rates while undergoing treatment with Artemisinin or quinine-based therapy reach 15% and 22% respectively. 2 There is, therefore, a need to develop an adjunct therapy to preserve neurological function during the treatment period. Recent experimental research has indicated hyperbaric oxygenation (HBO) to be a rational and effective adjunct therapy. 3 This article examines the current understanding of CM, and the possible benefits provided by HBO therapy.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1477893911000731; http://dx.doi.org/10.1016/j.tmaid.2011.07.003; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80054826030&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/21807563; https://linkinghub.elsevier.com/retrieve/pii/S1477893911000731; https://dx.doi.org/10.1016/j.tmaid.2011.07.003
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know